<?xml version="1.0" encoding="UTF-8"?>
<p id="Par30">Several neurological disorders in humans have raised particular interest for stem cell-based therapy, including multiple sclerosis, spinal cord injury, Parkinson's disease, stroke, Huntington's disease, amyotrophic lateral sclerosis, and Alzheimer's disease, which have been studied in experimental models and clinical trials [
 <xref ref-type="bibr" rid="CR13">13</xref>–
 <xref ref-type="bibr" rid="CR19">19</xref>]. In equine medicine, neurological disorders affecting the brain and spinal cord can present a therapeutic challenge [
 <xref ref-type="bibr" rid="CR20">20</xref>–
 <xref ref-type="bibr" rid="CR23">23</xref>] and many horses with neurological diseases such as equine protozoal myeloencephalitis (EPM) and cervical vertebral compressive myelopathy (CVCM or 'Wobbler's disease') can have neurological sequelae even after the recommended treatment.
</p>
